S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

SGMT Sagiment Biosciences Inc

4.9694

0.4794 (10.68%)

04 Jan 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Sagiment Biosciences (NASDAQ:SGMT)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Sagiment Biosciences Charts.

Sagiment Biosciences (NASDAQ:SGMT)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Sagiment Biosciences Charts.

Sagiment Biosciences Inc News

Form 8-K - Current report
Friday 3 January 2025 (3 days ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 27 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 17 August 2024 (5 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Friday 16 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 14 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 6 August 2024 (5 months ago) • Edgar (US Regulatory)

More Sagiment Biosciences Inc News Articles

Deutsche Rohstoff

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions